Quadrant Capital Group LLC Novo Nordisk A S Transaction History
Quadrant Capital Group LLC
- $2.65 Billion
- Q1 2025
A detailed history of Quadrant Capital Group LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Quadrant Capital Group LLC holds 107,817 shares of NVO stock, worth $4.89 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
107,817
Previous 35,393
204.63%
Holding current value
$4.89 Million
Previous $3.04 Million
145.93%
% of portfolio
0.28%
Previous 0.21%
Shares
31 transactions
Others Institutions Holding NVO
# of Institutions
1,749Shares Held
339MCall Options Held
11MPut Options Held
15.9M-
Jennison Associates LLC18.9MShares$857 Million0.78% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$671 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$562 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$559 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$539 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $102B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...